These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 25528467

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC.
    PLoS One; 2010 May 07; 5(5):e10527. PubMed ID: 20479873
    [Abstract] [Full Text] [Related]

  • 5. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.
    Van Rie A, Westreich D, Sanne I.
    J Acquir Immune Defic Syndr; 2011 Apr 07; 56(4):349-55. PubMed ID: 20926954
    [Abstract] [Full Text] [Related]

  • 6. Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.
    Ndlovu Z, Chirwa T, Takuva S.
    Pan Afr Med J; 2014 Apr 07; 19():114. PubMed ID: 25722787
    [Abstract] [Full Text] [Related]

  • 7. Hematologic alterations and early mortality in a cohort of HIV positive African patients.
    Ciccacci F, Lucaroni F, Latagliata R, Morciano L, Mondlane E, Balama M, Tembo D, Gondwe J, Orlando S, Palombi L, Marazzi MC.
    PLoS One; 2020 Apr 07; 15(11):e0242068. PubMed ID: 33170905
    [Abstract] [Full Text] [Related]

  • 8. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD.
    PLoS One; 2012 Apr 07; 7(3):e34156. PubMed ID: 22479548
    [Abstract] [Full Text] [Related]

  • 9. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
    Bock P, Jennings K, Vermaak R, Cox H, Meintjes G, Fatti G, Kruger J, De Azevedo V, Maschilla L, Louis F, Gunst C, Grobbelaar N, Dunbar R, Limbada M, Floyd S, Grimwood A, Ayles H, Hayes R, Fidler S, Beyers N.
    J Acquir Immune Defic Syndr; 2018 Jan 01; 77(1):93-101. PubMed ID: 29016524
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade.
    Wolday D, Kebede Y, Legesse D, Siraj DS, McBride JA, Kirsch MJ, Striker R.
    PLoS One; 2020 Jan 01; 15(5):e0233049. PubMed ID: 32442166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L, Atkinson A, Boulle A, Fox MP, Prozesky H, Zürcher K, Ballif M, Furrer H, Zwahlen M, Davies MA, Egger M, International Epidemiology Database to Evaluate AIDS in Southern Africa (IeDEA-SA).
    J Int AIDS Soc; 2017 Jun 23; 20(1):21327. PubMed ID: 28691438
    [Abstract] [Full Text] [Related]

  • 14. Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.
    Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N, Boulle A, Wehbe F, Masys D, Iriondo-Perez J, Hemingway-Foday J, Law M, Western Africa, Eastern Africa, Southern Africa, Caribbean and Central and South America, and Asia Pacific Regions of the International Epidemiologic Databases to Evaluate AIDS-IeDEA.
    J Int AIDS Soc; 2012 Jan 30; 15(1):5. PubMed ID: 22289654
    [Abstract] [Full Text] [Related]

  • 15. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD, Myer L, Bekker LG, Wood R.
    AIDS; 2006 Aug 01; 20(12):1605-12. PubMed ID: 16868441
    [Abstract] [Full Text] [Related]

  • 16. Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo.
    Akilimali PZ, Kashala-Abotnes E, Musumari PM, Kayembe PK, Tylleskar T, Mapatano MA.
    PLoS One; 2015 Aug 01; 10(10):e0140240. PubMed ID: 26474481
    [Abstract] [Full Text] [Related]

  • 17. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA, Dicko F, Kouéta F, Malateste K, Gueye RD, Aka E, Eboua TK, Azondékon A, Okomo U, Touré P, Ekouévi D, Leroy V, IeDEA West Africa Paediatric Collaboration.
    J Int AIDS Soc; 2013 Sep 17; 16(1):18024. PubMed ID: 24047928
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China.
    Mijiti P, Yuexin Z, Min L, Wubuli M, Kejun P, Upur H.
    Int J STD AIDS; 2015 Mar 17; 26(3):156-64. PubMed ID: 24810220
    [Abstract] [Full Text] [Related]

  • 19. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A, Desta K, Bezabih A, Gashaye A, Kassa D.
    Ethiop Med J; 2012 Jan 17; 50(1):13-21. PubMed ID: 22519158
    [Abstract] [Full Text] [Related]

  • 20. Anaemia in HIV-infected children: severity, types and effect on response to HAART.
    Nyesigire Ruhinda E, Bajunirwe F, Kiwanuka J.
    BMC Pediatr; 2012 Oct 31; 12():170. PubMed ID: 23114115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.